• Home

• Small Molecules: Hit identification

• Small Molecules: Hit-to-Lead optimization

• Small Molecules: physicochemical properties

• Small Molecules: ADME

• Small Molecules: Toxicity

• Small Molecules: Selectivity

• Antibodies: Humanization and Optimization

• Protein Modeling. Discovery

• Protein Modeling: HERG binding

• Protein Modeling: Albumin binding

• Quantum Discussions Forum    

Management team

Quantum Pharmaceuticals has assembled an international team of professionals who use their diverse talents to achieve Quantum Pharmaceuticals’ long-term and short-term goals. Our senior management team includes individuals with degrees in mathematics, economics, physics, law, finance, and international business.

Andrei Vinnik, Ph.D.

Chief Executive Officer
Ph.D., Applied Mathematics and Economics Moscow Institute of Physics and Technology

Peter Fedichev, Ph.D.

Chief Scientific Officer
Ph.D., Theoretical Physics Moscow Institute of Physics and Technology
Assistant Professor Institute of Theoretical Physics University of Innsbruck

Maxim Kholin

Director Business Development
Post Graduate degree Moscow Law Academy
M.S. degree The Finance Academy
M.S. degree Moscow Law Academy